scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023913531 |
P356 | DOI | 10.1186/S12902-016-0101-2 |
P932 | PMC publication ID | 4890276 |
P698 | PubMed publication ID | 27255309 |
P50 | author | Robert Alan Greevy | Q89613050 |
Marie R. Griffin | Q89613053 | ||
Christianne L. Roumie | Q89613055 | ||
Carlos G. Grijalva | Q89613057 | ||
P2093 | author name string | Adriana M Hung | |
Xulei Liu | |||
P2860 | cites work | Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations | Q22241134 |
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Q22241288 | ||
Patient perceptions of quality of life with diabetes-related complications and treatments | Q24644699 | ||
Diabetes in older adults | Q30528669 | ||
Estimating medication persistency using administrative claims data. | Q30996673 | ||
Service utilization of veterans dually eligible for VA and Medicare fee-for-service: 1999-2004. | Q33551536 | ||
Treatment intensification and risk factor control: toward more clinically relevant quality measures | Q33988413 | ||
Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling | Q34065562 | ||
Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes | Q34109319 | ||
Drug titration patterns and HbA 1c levels in type 2 diabetes | Q34322132 | ||
Validation of VA administrative data algorithms for identifying cardiovascular disease hospitalization | Q34573073 | ||
Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study | Q34644993 | ||
Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. | Q34988073 | ||
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications | Q35141566 | ||
Comparative effectiveness of incident oral antidiabetic drugs on kidney function | Q35835288 | ||
Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study | Q35864363 | ||
Standards of medical care in diabetes--2009. | Q37036416 | ||
Medication compliance and persistence: terminology and definitions | Q37072950 | ||
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials | Q37866586 | ||
Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis. | Q38001085 | ||
The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure | Q38042350 | ||
Veterans' access to and use of Medicare and Veterans Affairs health care | Q38463957 | ||
Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. | Q44453230 | ||
Changing incident diabetes regimens: a Veterans Administration cohort study from 2000 to 2005. | Q45332206 | ||
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
Executive summary: standards of medical care in diabetes--2009 | Q56481478 | ||
P433 | issue | 1 | |
P304 | page(s) | 32 | |
P577 | publication date | 2016-06-02 | |
P1433 | published in | BMC Endocrine Disorders | Q4835945 |
P1476 | title | Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study | |
P478 | volume | 16 |
Q49967667 | Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study |
Q90177360 | Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function |
Q46441179 | Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline. |
Q38829782 | Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study |
Q92544171 | Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes |
Q43540210 | Second-Line Agents for the Treatment of Type 2 Diabetes and Prevention of CKD. |
Q28078294 | The neurobiology of the Prader-Willi phenotype of fragile X syndrome |
Search more.